Group B Streptococcus
E902870
Group B Streptococcus is a type of bacteria commonly found in the gastrointestinal and genital tracts that can cause serious infections in newborns, pregnant women, and adults with weakened immune systems.
Statements (63)
| Predicate | Object |
|---|---|
| instanceOf |
Gram-positive coccus
ⓘ
bacterial species ⓘ beta-hemolytic Streptococcus ⓘ human pathogen ⓘ |
| abbreviation | GBS NERFINISHED ⓘ |
| alsoKnownAs | Streptococcus agalactiae NERFINISHED ⓘ |
| alternativeTreatment |
cefazolin
ⓘ
clindamycin ⓘ vancomycin ⓘ |
| capsule | encapsulated ⓘ |
| catalaseActivity | catalase-negative ⓘ |
| causesDisease |
adult meningitis
ⓘ
bacteremia in adults ⓘ cellulitis ⓘ chorioamnionitis ⓘ early-onset neonatal sepsis ⓘ late-onset neonatal sepsis ⓘ neonatal meningitis ⓘ neonatal pneumonia ⓘ osteomyelitis ⓘ postpartum endometritis ⓘ septic arthritis ⓘ urinary tract infection in pregnancy ⓘ |
| cellArrangement | chains ⓘ |
| cellMorphology | coccus ⓘ |
| colonizationRateInPregnancy | approximately 10–30 percent of pregnant women ⓘ |
| colonizes |
rectum
ⓘ
vagina ⓘ |
| diagnosisMethod |
blood culture
ⓘ
cerebrospinal fluid culture ⓘ culture from vaginal and rectal swabs ⓘ |
| domain | Bacteria ⓘ |
| family | Streptococcaceae NERFINISHED ⓘ |
| firstLineTreatment |
ampicillin
GENERATED
ⓘ
penicillin G GENERATED ⓘ |
| genus | Streptococcus NERFINISHED ⓘ |
| gramStain | Gram-positive ⓘ |
| hemolysisType | beta-hemolytic ⓘ |
| LancefieldGroup | group B ⓘ |
| majorVirulenceFactor |
beta-hemolysin
ⓘ
polysaccharide capsule ⓘ surface proteins ⓘ |
| naturalHabitat |
human gastrointestinal tract
ⓘ
human genital tract ⓘ |
| order | Lactobacillales NERFINISHED ⓘ |
| oxygenRequirement | facultative anaerobe ⓘ |
| preventionMethod | intrapartum antibiotic prophylaxis ⓘ |
| publicHealthImpact | leading cause of neonatal sepsis and meningitis in many countries ⓘ |
| riskGroup |
immunocompromised adults
ⓘ
newborns ⓘ older adults ⓘ pregnant women ⓘ |
| screeningRecommendation | universal screening of pregnant women at 35–37 weeks gestation ⓘ |
| serotypes |
II
ⓘ
III ⓘ Ia ⓘ Ib ⓘ V ⓘ |
| taxonRank | species ⓘ |
| transmissionRoute |
ascending infection from vagina
ⓘ
person-to-person contact ⓘ vertical transmission during childbirth ⓘ |
| vaccineStatus | no licensed vaccine as of 2024 ⓘ |
Referenced by (1)
Full triples — surface form annotated when it differs from this entity's canonical label.